Karur Vysya 1Q net interest margin 3.86% est. 3.85% (2 est.)

Thursday, Jul 24, 2025 7:23 am ET1min read

Karur Vysya 1Q net interest margin 3.86% est. 3.85% (2 est.)

Karur Vysya Bank has reported robust financial performance for the quarter ended June 2025, with significant growth in both operating income and net profit. The bank's total operating income rose by 12.43% to Rs 2568.55 crore, while its net profit surged by 13.69% to Rs 521.45 crore [1].

The bank's net interest margin (NIM) is estimated to be 3.86%, slightly higher than the previous estimate of 3.85% [2]. This indicates a strong performance in the bank's core interest-earning activities. The bank's profit before depreciation and taxation (PBDT) also saw an increase of 12%, reaching Rs 687.36 crore.

Karur Vysya Bank's share price, however, has been relatively stable, trading at Rs 270.00, a decrease of 0.37% from its last closing price. The stock has been trading in the range of Rs 273.10 to Rs 268.10, with a year-to-date performance of 24.95% and a 5-day return of -0.99% [2].

Analysts have shown varied opinions on the stock, with 13 analysts covering the company. The stock has received a strong buy rating from 3 analysts and a buy rating from 5 analysts, while 1 analyst has given it a sell rating [2].

Mutual fund holdings in Karur Vysya Bank have decreased to 31.49%, while foreign institutional investor (FII) holdings have increased to 15.12% [2].

Overall, Karur Vysya Bank's Q1 2025 results demonstrate a strong financial position, driven by robust operating income and net profit growth. The bank's performance is notable, especially given the recent market conditions.

References:
[1] https://www.business-standard.com/markets/capital-market-news/karur-vysya-bank-standalone-net-profit-rises-13-69-in-the-june-2025-quarter-125072400991_1.html
[2] https://www.livemint.com/market/market-stats/stocks-karur-vysya-bank-share-price-nse-bse-s0003253

Karur Vysya 1Q net interest margin 3.86% est. 3.85% (2 est.)

Comments



Add a public comment...
No comments

No comments yet